MORGANS DAVID J JR 4
4 · CYTOKINETICS INC · Filed Oct 2, 2009
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
MORGANS DAVID J JR
EVP-Preclinical R&D
Transactions
- Sale
Common Stock
2009-10-01$5.23/sh−200$1,046→ 42,200 total - Sale
Common Stock
2009-10-01$5.19/sh−4,400$22,836→ 44,334 total - Sale
Common Stock
2009-10-01$5.20/sh−534$2,777→ 43,800 total - Sale
Common Stock
2009-10-01$5.17/sh−766$3,960→ 48,734 total - Sale
Common Stock
2009-10-01$5.22/sh−1,400$7,308→ 42,400 total
Holdings
- 50,190
Non-Qualified Stock Option (right to buy)
Exercise: $6.81From: 2007-04-01Exp: 2017-03-14→ Common Stock (50,190 underlying) - 14,005
Non-Qualified Stock Option (right to buy)
Exercise: $6.59From: 2005-04-11Exp: 2015-04-11→ Common Stock (14,005 underlying) - 106,249
Non-Qualified Stock Option (right to buy)
Exercise: $1.85From: 2009-03-26Exp: 2019-02-26→ Common Stock (106,249 underlying) - 43,751
Incentive Stock Option (right to buy)
Exercise: $1.85From: 2009-03-26Exp: 2019-02-26→ Common Stock (43,751 underlying) - 122,286
Non-Qualified Stock Option (right to buy)
Exercise: $3.37From: 2008-03-29Exp: 2018-02-28→ Common Stock (122,286 underlying) - 15,388
Incentive Stock Option (right to buy)
Exercise: $7.15From: 2006-03-01Exp: 2016-03-01→ Common Stock (15,388 underlying) - 44,612
Non-Qualified Stock Option (right to buy)
Exercise: $7.15From: 2006-03-01Exp: 2016-03-01→ Common Stock (44,612 underlying) - 27,714
Incentive Stock Option (right to buy)
Exercise: $3.37From: 2008-03-29Exp: 2018-02-28→ Common Stock (27,714 underlying) - 35,995
Incentive Stock Option (right to buy)
Exercise: $6.59From: 2005-04-11Exp: 2015-04-11→ Common Stock (35,995 underlying) - 34,000
Incentive Stock Option (right to buy)
Exercise: $6.50From: 2004-04-08Exp: 2014-03-08→ Common Stock (34,000 underlying) - 14,810
Incentive Stock Option (right to buy)
Exercise: $6.81From: 2007-04-01Exp: 2017-03-14→ Common Stock (14,810 underlying)
Footnotes (7)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 30, 2008.
- [F2]When the ISO and NQ dated 02/26/2009 are combined for a total grant of 150,000 shares, the option shall vest and become exercisable as to 3,125 shares on 03/26/09 and the balance of 146,875 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/26/13.
- [F3]When the ISO and NQ dated 02/29/2008 are combined for a total grant of 150,000 shares, the option shall vest and become exercisable as to 3,125 shares on 03/29/08 and the balance of 146,875 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/29/12.
- [F4]This option shall vest and become exercisable as to 708 shares on 04/08/04 and the balance of 33,292 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/08/08.
- [F5]When the ISO and NQ dated 04/11/05 are combined for a total grant of 50,000 shares, the option shall vest and become exercisable as to 50,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2009.
- [F6]When the ISO and NQ dated 03/14/2007 are combined for a total grant of 65,000 shares, the option shall vest and become exercisable as to 1,354 shares on 04/01/07 and the balance of 63,646 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/11.
- [F7]When the ISO and NQ dated 03/01/2006 are combined for a total grant of 60,000 shares, the option shall vest and become exercisable as to 60,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2010.